These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4256472)

  • 1. Antibody formation for malignant tumor. 3. Antigenicity of peptide of ribosomal digest in Ehrlich ascites tumor.
    Yamamoto Y; Jituiki D; Yabuki Y
    Acta Med Okayama (1952); 1970 Oct; 24(5):534-7. PubMed ID: 4256472
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody formation for malignant tumor. II. Antigenicity of Ehrlich ascites tumor lipoprotein.
    Yamamoto Y; Tadatomo Y; Okamura S
    Acta Med Okayama (1952); 1970 Oct; 24(5):527-36. PubMed ID: 4256471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gel filtration and immunoelectrophoresis of serum proteins in tumors and in tissue regressive processes].
    Brucchieri A; Billitteri A
    Sperimentale; 1969; 119(6):447-53. PubMed ID: 5406738
    [No Abstract]   [Full Text] [Related]  

  • 4. Mouse immune ascites in immunoelectrophoresis.
    Wager O; Räsänen JA
    Ann Med Exp Biol Fenn; 1967; 45(2):170-3. PubMed ID: 4963438
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary report. Antigenicity of the mice Ehrlich ascitic tumor cell nuclei.
    Zitnan D; Cebecauer L; Ujházy V
    Neoplasma; 1969 Jun; 16(3):339-41. PubMed ID: 4981697
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface antigen on Ehrlich ascites tumor cells.
    Pessina A; Brambilla P; Mocarelli P
    Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of Ehrlich ascites tumor growth by nucleoprotein. II. In vivo fate of the tumor cells.
    Bradshaw LJ; Webb DR
    J Natl Cancer Inst; 1969 Sep; 43(3):527-32. PubMed ID: 4980604
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the question of immunology of tumors. 3. A model on the example of Ehrlich ascites tumor].
    Karrer K; Letnansky K; Speiser P
    Wien Med Wochenschr; 1966 Sep; 116(38):773-6. PubMed ID: 4169571
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunogenicity of cancer-associated and cancer-specific antigens].
    del Pozo AM; Valladares Y; Alvarez-Rodríguez Y; Alvarez-Noves J
    Rev Esp Oncol; 1982; 29(4):685-700. PubMed ID: 6927369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody formation for malignant tumor. I. Antitumor activity of the regional lymph node protein.
    Yamamoto Y; Nakashima Y; Okano Y
    Gan; 1968 Apr; 59(2):109-16. PubMed ID: 5723055
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolution of the immune response. 13. The characterization of purified erythrocyte agglutinins from two invertebrate species.
    Finstad CL; Litman GW; Finstad J; Good RA
    J Immunol; 1972 Jun; 108(6):1704-11. PubMed ID: 4624179
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S; Mondal S
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological and biochemical activity of anti-ribosome immune serum.
    Merétey K; Holland J; Várterész V
    Acta Microbiol Acad Sci Hung; 1970; 17(2):175-83. PubMed ID: 4992459
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterophile antigens in Ehrlich ascites fluid.
    Eng CP; Hindmarsh JA; Morgan JF
    Can J Microbiol; 1969 Dec; 15(12):1409-13. PubMed ID: 4983960
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
    Sur P; Roy DK
    Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
    [No Abstract]   [Full Text] [Related]  

  • 17. Equine immunoglobulins: a comparison of molecular properties.
    Buchowicz I; Goch H; Zakrzewski K
    Acta Biochim Pol; 1969; 16(3):279-96. PubMed ID: 4983874
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural analysis of a slowly sedimenting proteolytic fragment of human immunoglobulin M.
    Goodman A; Inman FP
    J Immunol; 1969 Apr; 102(4):1032-41. PubMed ID: 4181245
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunity and tumors].
    Michelazzi L
    Boll Ist Sieroter Milan; 1971; 50(3):185-91. PubMed ID: 4337946
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenicity of polypeptides (poly alpha amino acids): calcium-dependent and independent antibodies.
    Maurer PH; Clark LG; Liberti PA
    J Immunol; 1970 Sep; 105(3):567-73. PubMed ID: 4195495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.